Diabetes managment: Beyond hemoglobin A1c

Vinni Makin; M Cecilia Lansang

doi:10.3949/ccjm.86a.18031

Diabetes managment: Beyond hemoglobin A_1c

Cleve Clin J Med. 2019 Sep;86(9):595-600. doi: 10.3949/ccjm.86a.18031.

Authors

Vinni Makin^{1

2

3}, M Cecilia Lansang^{4

5

6}

Affiliations

¹ Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH, USA. makinv@ccf.org.
² Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
³ Clinical Assistant Professor, Ohio Heritage College of Osteopathic Medicine, Cleveland, OH, USA.
⁴ Director, Inpatient Diabetes Service; Chair, Cleveland Clinic Health Systems Diabetes Care Committee, Cleveland, OH, USA.
⁵ Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH, USA.
⁶ Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

PMID: 31498766
DOI: 10.3949/ccjm.86a.18031

Abstract

Diabetes management is a tailored affair. Patients live with the disease for decades and need increasingly complicated treatment regimens to attain glycemic goals. But other goals such as cardiovascular risk reduction, weight control, and avoidance of hypoglycemia also need consideration.

Publication types

Review

MeSH terms

Blood Glucose / analysis
Cardiovascular Diseases / etiology
Cardiovascular Diseases / prevention & control*
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / therapy*
Disease Management*
Glycated Hemoglobin / analysis*
Humans
Hypoglycemia / etiology
Hypoglycemia / prevention & control*
Hypoglycemic Agents / therapeutic use
Patient Care Planning
Weight Loss

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
hemoglobin A1c protein, human